Medical AI can matter before it becomes a better doctor

There is something worth celebrating in an AI system that helps a person actually get a test. Two new Nature Communications studies focus attention on access and the practical work of acquiring medical information, rather than a sweeping claim that software replaces clinicians. That is a useful change of emphasis. The ACCESS2 study examined point-of-care autonomous diabetic-eye screening in 397 young people with diabetes. Screening completion reached 99.5% among White participants and 98% among non-White participants, compared with lower and more unequal prior completion. Those are encouraging access results. They do not establish that treatment was received or vision improved. The reported 100% sensitivity also has a wide 95% confidence interval of 67.6–100%; it should not be presented as diagnostic perfection. Specificity was 76%, so the downstream assessment pathway matters. A separate study evaluated an AI-guided, patient-mounted ultrasound system in 102 healthy participants and 17 patients. Its 588-gram figure describes the end-effector, not necessarily the entire system. The authors report interpretable liver images and promising acquisition performance, including field-oriented demonstrations. This is feasibility evidence, not proof that a portable robot can replace an experienced clinician across settings. The shared opportunity is concrete: reduce the distance between someone and a useful examination. My appreciation comes with a practical condition. A positive screen needs confirmation, an explanation and access to care. If the test arrives but the referral pathway does not, we may move the bottleneck rather than remove it. Still, making the first step easier is real progress worth investigating—not a consolation prize for failing to automate the whole profession.